K33PI3K-AktCTL

Yi Yun Liang1, Xiao Yan Liao1, Jun Jun Jia1

  • 1Department of Basic Medicine Science, School of Medicine, Xiamen University, Xiamen, Fujian, People's Republic of China.

Immunology
|March 28, 2024
PubMed
概括

只有K33突变型的乌比奎丁可以增强树突细胞功能和T细胞原始化. 这通过PI3K-Akt途径发生,促进免疫反应.